La cadena de opciones muestra datos clave de las opciones de acciones de Check-Cap a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Check-Cap..

Check-Cap (NASDAQ:CHEK) Bolsa, Cadena de Opciones

Check-Cap

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Movers

Trading Ideas

ARKR

AURA

BLRX

CHEK

CMCT

COEP

IDAI

LINC

MGOL

NINE

RSVR

Conoce las acciones que lideran el premercado tras movimientos clave: Check-Cap sube un 52,2% gracias a nueva patente.

Las acciones de Check-Cap suben un 52%; 20 acciones que se están moviendo antes de la apertura del mercado

News

Pre-Market Outlook

Markets

AMPG

AVGR

BIPC

CREV

FDSB

HSDT

KORE

LAES

LIND

NCRA

NEUE

NVNI

RELI

SLGL

TIVC

TLRY

TOVX

Carbon Revolution lidera con un aumento del 62,4% en el premercado. ¿Qué otras acciones destacaron antes de la apertura?

Las acciones de Carbon Revolution (CREV) están subiendo un 62%; 20 acciones que se están moviendo en el premercado

Check-Cap Ltd

Zscaler Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) shares rallied in early trading on Friday, after the company on Thursday reported <a href="https://www.benzinga.com/news/earnings/25/05/45683134/zscaler-beats-q3-earnings-estimates-raises-guidance-increases-investments-in-ai">upbeat results for its fiscal third quarter</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
<h1 class="wp-block-heading">Piper Sandler On Zscaler</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/590783e6290fa70001409b4a/rob-owens">Analyst </a><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/590783e6290fa70001409b4a/rob-owens">Rob Owens</a> downgraded the rating from Overweight to Neutral, while raising the price target from $235 to $260.
Zscaler reported solid results for the fiscal third quarter, with billings and revenues surpassing Street expectations, "while new products continue to gain traction," Owens said in the downgrade note. Revenues grew 23% year-on-year to $678 million, coming in above the guidance midpoint by 1.8%, he added.
Calculated billings grew 26% year-on-year to $785 million, beating Street expectations by $25 million, the analyst stated. "However, as we contemplate the recent momentum of the stock and incremental near-term risks in the Red Canary acquisition integration + Fed uncertainty, we believe shares are fairly balanced at current levels," he further wrote.
<h1 class="wp-block-heading">RBC Capital Markets On Zscaler</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5880b6f377f9dd00011b0ab2/matthew-hedberg">Analyst Matthew Hedberg</a> maintained an Outperform rating, while lifting the price target from $288 to $304.
Zscaler reported strong quarterly results, "with outperformance across the board against high investor expectations," Hedberg said. The company did not experience any "noticeable impact" from tariffs, he added.
Management raised their full-year guidance across the board, projecting revenue and billings growth of 23% and 21.5%, up from their prior outlook of 22% and 20.5%, respectively, the analyst stated. "Like cyber peers, Zscaler introduced Z-Flex, a new purchasing program to ease procurement and increase module adoption," he further wrote.
<h1 class="wp-block-heading">Citizens On Zscaler</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6298be750c34880001d668d9/trevor-walsh">Analyst Trevor Walsh</a> reiterated a Market Outperform rating, while raising the price target from $240 to $310.
Zscaler reported non-GAAP earnings of 84 cents per share, beating consensus of 76 cents per share, Walsh said. The company announced the appointment of Kevin Rubin as chief financial officer, he added.
Zscaler announced plans to acquire managed detection and response (MDR) provider Red Canary to boost its AI-powered security operations center (SOC) capabilities, the analyst wrote. The acquisition is expected to close in August 2025, he added.
<h1 class="wp-block-heading">KeyBanc Capital Markets On Zscaler</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/62eacb8a9bab060001dbd41a/eric-heath">Analyst Eric Heath</a> reaffirmed an Overweight rating, while taking the price target higher from $290 to $310.
Zscaler reported a strong beat in the quarter, with ARR (annual recurring revenue) growing 23% year-on-year to around $2.9 billion, Heath said. Billings came in at $785 million, beating consensus of $761 million, he added.
Management's guidance implied billings of $1,140-$1,145M million for the fiscal fourth quarter, representing 25%-26% year-on-year growth, in-line with expectations, the analyst stated. "We see strong momentum in the SASE market, a strengthening portfolio of emerging products to cross-sell, and an experienced GTM leadership team selling to the C-suite," he further wrote.
<h1 class="wp-block-heading">Truist Securities On Zscaler</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/57fdefd3ac6af40001334e3e/joel-fishbein">Analyst Joel Fishbein</a> maintained a Buy rating, while lifting the price target from $260 to $300.
Zscaler reported a record quarter, with more than $1 billion in in TCV (total contract value) bookings, Fishbein said. The company's strong results were "driven by improving sales productivity and lower attrition," he added.
Zscaler witnessed growing customer demand for the platform, "in particular Zero Trust Everywhere, Data Security Everywhere, and Agentic Operations solutions," the analyst wrote. Management flowed the beat to their full-year outlook, he further stated.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<h1 class="wp-block-heading">Wedbush On Zscaler</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e00ad4e3513fb0001f03cfd/daniel-ives">Analyst Daniel Ives</a> maintained an Outperform rating, while raising the price target from $240 to $300.
Zscaler reported a beat across the board, with strong billings due to continued robust demand for its zero trust and AI security solutions, Ives said.
"Management announced on the call that starting in FY26, the company will switch from billings to ARR as the main metric to properly use for ZS going forward," he further wrote.
<h1 class="wp-block-heading">Cantor Fitzgerald On Zscaler</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58d11d3db85e93000188d7b9/jonathan-ruykhaver">Analyst Jonathan Ruykhaver</a> reiterated an Overweight rating, while raising the price target from $275 to $290.
Zscaler's revenue and cRPO (current remaining performance obligation) bookings grew 23%, "reflecting strong customer demand for the Zero Trust Exchange platform," Ruykhaver said. The company's emerging growth categories, Zero Trust Everywhere, Data Security Everywhere and Agentic Operations, were the key drivers, with combined ARR of around $1 billion, he added.
Customers contributing $1 million in ARR grew 27% year-on-year in the quarter, while those spending over $100,000 grew 18% to 3,363, the analyst further stated.
<h1 class="wp-block-heading">Needham On Zscaler</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/601a8839a6fe6f00010c6966/mike-cikos">Analyst Mike Cikos</a> reaffirmed a Buy rating, while lifting the price target from $240 to $310.
Zscaler reported "another strong quarter," outperforming billings expectations again, Cikos said. Management raised their full-year billings guidance "by passing through the entirety of the upside in 3QFY25 and nudging 4QFY25 slightly higher," he added.
"We believe the platform expansion and go-to-market changes under Chief Revenue Officer Mike Rich are taking hold as Zscaler looks to emulate the ServiceNow model by driving deeper, more strategic relationships with customers while gaining greater wallet-share," the analyst wrote.
<h1 class="wp-block-heading">Rosenblatt Securities On Zscaler</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/585aa876b5a482000151d0ed/catharine-trebnick">Analyst Catharine Trebnick</a> reiterated a Buy rating, while raising the price target from $235 to $315.
Zscaler delivered a "standout" performance in the quarter, exceeding expectations on growth and profitability, Trebnick said. Operating margin came in at 21.6%, around 40 basis points (bps) higher than Street expectations, she added.
"The company remains on a path toward its long-term $5B+ ARR target, supported by strategic initiatives like the acquisition of Red Canary and the appointment of a new CFO," the analyst wrote.
<h1 class="wp-block-heading">Stephens On Zscaler</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/67ebeaa15b91ab00015a8af3/todd-weller%20">Analyst Todd Weller</a> maintained an Overweight rating and price target of $255.
Zscaler's billings beat consensus by 3.2%, while revenue by 1.8%, Weller said.
"Zscaler also announced Kevin Rubin as new CFO. Mr. Rubin was previously CFO of Alteryx, an AI and cloud analytics platform provider that was acquired by Clearlake Capital and Insight Partners in March 2024," the analyst wrote.
<h1 class="wp-block-heading">Guggenheim Securities On Zscaler</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587f78d077f9dd000126ef0f/john-difucci">Analyst John DiFucci</a> reaffirmed a Neutral rating on the stock.
Zscaler's results beat consensus estimates across the board and the company raised its full-year guidance, "which is about as good as it gets relative to expectations in the security sector this quarter," DiFucci said.
Growth in new ACV was modestly better than the previous quarter's 1% growth and the third quarter "had the easiest comp of the year," which implies that "business momentum (as measured by a 2-year stack of New ACV growth) modestly deteriorated in F3Q," the analyst wrote.
ZS Price Action: Shares of Zscaler had risen by 8.56% to $272.27 at the time of publication on Friday.
Read More: • <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45477478/whats-next-for-foot-locker-analyst-says-dicks-deal-is-timely">What&#8217;s Next For Foot Locker? Analyst Says Dick&#8217;s Deal Is Timely</a>

Photo: Sundry Photography via Shutterstock

Earnings Beats

Zscaler Stock Jumps On Q3 Report: 'Another Strong Quarter,' Company Did Not Experience Any 'Noticeable Impact' From Tariffs

Truist Securities analyst Patrick Scholes downgrades Park Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>) from Buy to Hold and lowers the price target from $16 to $11.

Downgrades

Price Target

Analyst Ratings

Truist Securities Downgrades Park Hotels & Resorts to Hold, Lowers Price Target to $11

Macro Economic Events

Economics

Federal Reserve

Live On CNBC, JPMorgan CEO Jamie Dimon At Reagan National Economic Forum Says AI May Be Deflationary, But Not Next Year

Truist Securities analyst Bill Chappell maintains e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) with a Buy and raises the price target from $75 to $125.

Truist Securities Maintains Buy on e.l.f. Beauty, Raises Price Target to $125

Truist Securities analyst Ki Bin Kim reiterates Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Buy and raises the price target from $260 to $300.

Reiteration

Truist Securities Reiterates Buy on Zscaler, Raises Price Target to $300

Truist Securities analyst Peter Osterland maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Buy and lowers the price target from $117 to $92.

Truist Securities Maintains Buy on Westlake, Lowers Price Target to $92

Truist Securities analyst Terry Tillman maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Hold and raises the price target from $12 to $13.

PATH

Truist Securities Maintains Hold on UiPath, Raises Price Target to $13

WIIM

BLUE

BLUE stock has given up its prior loss. Bluebird Bio shares were trading lower after the acquisition bid for the company has expired without extension.

Truist Securities analyst Patrick Scholes maintains Ryman Hospitality Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHP#NYSE">RHP</a>) with a Buy and lowers the price target from $127 to $120.

Truist Securities Maintains Buy on Ryman Hospitality Props, Lowers Price Target to $120

<a href="https://www.bloomberg.com/news/articles/2025-05-30/us-plans-wider-china-tech-sanctions-with-subsidiary-crackdown?srnd=homepage-americas&amp;embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-30/us-plans-wider-china-tech-sanctions-with-subsidiary-crackdown?srnd=homepage-americas&amp;embedded-checkout=true</a>

General

'US Plans Wider China Tech Sanctions With Subsidiary Crackdown'- Bloomberg

Truist Securities analyst Joel Fishbein maintains PagerDuty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>) with a Buy and lowers the price target from $26 to $23.

Truist Securities Maintains Buy on PagerDuty, Lowers Price Target to $23

In the age of meme stocks, moonshot tech plays, and crypto quick wins, it might seem out of character for a young investor to get excited about Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), or Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), or a <a href="https://www.benzinga.com/etfs">dividend ETF</a> that doesn't promise to 10x your money overnight.
But a revolution is quietly cooking in the portfolios of Gen-Z&#8217;ers and Millennials who follow the FIRE philosophy — Financial Independence, Retire Early. And large part of this movement is a tactic your financial advisor&#8217;s father may have suggested: dividend growth investing. In that context, Schwab US Dividend Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHD#NYSE">SCHD</a>) is emerging as a solid contender for <a href="https://www.benzinga.com/etfs/specialty-etfs/25/05/45532640/schd-the-dividend-etf-turning-quiet-compounding-into-long-term-wealth">passive income investing</a>.
Let&#8217;s explore the mood further. SCHD has a low 0.06% expense ratio, pays a 4% dividend yield, and owns stalwarts such as Verizon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>), ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>), and Coca-Cola. The fund is tightly rules-based, emphasizing only those firms with 10 years of dividend payment, good fundamentals, and heavy trading volume.
And that&#8217;s what attracts FIRE followers. The emotional roller coaster involved in pursuing meme tickers and &#8220;to the moon&#8221; mania is bound to lose charm, and young investors are constructing long-term portfolios intended to accumulate wealth quietly, sustainably, and with little drama.
The Philosophy 
FIRE is not about instant wealth. It&#8217;s about working hard, investing harder, and retiring earlier than the conventional age of 65-70, on a self-directed, passive income stream robust enough to pay for everything.
Dividend growth investing checks all the boxes: It offers compounding income from quarterly payments, less volatility than high-beta growth stocks, protection against inflation as dividends rise with time, and sector diversification without the drudgery of selecting individual stocks.
And SCHD? It does it all, no Reddit forum necessary.
A Financial Workhorse
With assets of more than $67 billion and an average daily volume of more than 15 million shares, it&#8217;s a big player in the dividend ETF universe. Its top 10 holdings, such as Lockheed Martin, Cisco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), and Verizon, are among the most financially secure U.S. corporations. And its built-in guardrails, such as a sector exposure cap (no more than 25%) and focus on return on equity (29.06% as of April 30), prevent it from crossing into dangerous territory.
Even during periods of market volatility, SCHD&#8217;s performance has been robust due to its mix of consumer staples, healthcare, and energy exposure. It&#8217;s not cool, but it&#8217;s reliable. And in a FIRE portfolio, that is a superpower.
Final Thought
In an era where financial news streams are dominated by AI chip makers and blockchain soap operas, SCHD is working its magic behind the scenes, assisting investors in achieving their objectives one dividend check at a time. For the next generation pursuing financial independence, and not merely flashy charts, it might be just the turtle that outpaces all the hares on the track.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/cannabis/25/05/45692881/defiance-etfs-rolls-out-2x-leveraged-carvana-etf">As Carvana Stock Soars, Defiance ETFs Rolls Out 2X Leveraged CVNX ETF</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Specialty ETFs

CSCO

SCHD

From Meme Stocks To Mature Moves: Why SCHD Might Be A Good Bet For Young Investors For Passive Income Power

Truist Securities analyst Patrick Scholes maintains Marriott International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) with a Hold and lowers the price target from $300 to $273.

Truist Securities Maintains Hold on Marriott International, Lowers Price Target to $273

Live On CNBC, JPMorgan CEO Jamie Dimon At Reagan National Economic Forum Says Stress Tests Are A "Complete Waste Of Time"; Says We Were Quite Prepared For Rates Going To 5%; Says We Should Aspire To Grow At 3% A Year; Says ISS And Glass Lewis Are A "Cancer"; We Should Change How We Do No Broker Votes; Fed Is Right To Wait Now

Truist Securities analyst Patrick Scholes maintains Hyatt Hotels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>) with a Buy and lowers the price target from $156 to $140.

Truist Securities Maintains Buy on Hyatt Hotels, Lowers Price Target to $140

Barclays analyst Julian Mitchell maintains GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Overweight and raises the price target from $427 to $500.

Barclays Maintains Overweight on GE Vernova, Raises Price Target to $500

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday.
Shares of Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) rose sharply during Friday's session after the company reported better-than-expected first-quarter financial results and <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45695903/ulta-stock-is-rising-friday-whats-going-on">raised guidance</a>.
Ulta reported earnings per share of $6.70, beating the consensus estimate of $5.77. In addition, the company reported sales of $2.85 billion, beating the consensus estimate of $2.79 billion, and representing a 4.5% year-over-year gain.
Ulta Beauty shares jumped 11.2% to $469.27 on Friday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>LiveWire Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NASDAQ">LVWR</a>) shares jumped 54.5% to $4.43.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) gained 22.1% to $905.00.</li>
<li>Zhengye Biotechnology Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYBT#NASDAQ">ZYBT</a>) rose 16.1% to $9.50.</li>
<li>TSS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) gained 12.5% to $13.77.</li>
<li>Universal Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UVV#NYSE">UVV</a>) rose 11.4% to $66.16 following quarterly results.</li>
<li>Shoals Technologies Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) gained 11.3% to $4.7950.</li>
<li>NGL Energy Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGL#NYSE">NGL</a>) surged 11% to $3.5750 following fourth-quarter results.</li>
<li>Unity Software Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) gained 10.7% to $26.32 after Jefferies upgraded the stock from hold to buy and raised its price target from $22 to $29.</li>
<li>Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) rose 10.5% to $18.95.</li>
<li>GATX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GATX#NYSE">GATX</a>) gained 9.9% to $160.98 after Wells Fargo agreed to sell its Rail Leasing Business to the company for $4.4 billion through a joint purchase with Brookfield Infrastructure Partners.</li>
<li>BRP Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOOO#NASDAQ">DOOO</a>) surged 7.7% to $43.70 after TD Securities upgraded the stock from Hold to Buy.</li>
<li>Zscaler, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) rose 7.7% to $270.37 after better-than-expected earnings</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/05/45691209/top-3-materials-stocks-that-could-blast-off-this-month-2">Top 3 Materials Stocks That Could Blast Off This Month</a> </li>
</ul>
Photo via Shutterstock

DOOO

GATX

LVWR

PONY

SHLS

TSSI

ULTA

ZYBT

Ulta Beauty Posts Upbeat Results, Joins Unity Software, GATX And Other Big Stocks Moving Higher On Friday

Truist Securities analyst Patrick Scholes maintains Diamondrock Hospitality (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRH#NYSE">DRH</a>) with a Hold and lowers the price target from $10 to $9.

Truist Securities Maintains Hold on Diamondrock Hospitality, Lowers Price Target to $9

Truist Securities analyst Scot Ciccarelli maintains Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) with a Hold and raises the price target from $995 to $1042.

COST

Truist Securities Maintains Hold on Costco Wholesale, Raises Price Target to $1042

Barclays analyst Julian Mitchell maintains Emerson Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) with a Underweight and raises the price target from $104 to $112.

Barclays Maintains Underweight on Emerson Electric, Raises Price Target to $112

Small Cap

Press Releases

Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction

MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders

Apollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders

MEDIF

TSX:LABS

Comments

Check-Cap

Check-Cap (CHEK) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL